Home  »  Investing News   »  Some Investing Thoughts On DermTech Inc. (DMTK)...

Some Investing Thoughts On DermTech Inc. (DMTK)

DermTech Inc. (DMTK)  has developed an innovative skin cancer test with minimally invasive procedures, and test sales are on the rise. Insurance companies are willing to cover the cost of such testing.

Essentially, DermTech has developed a patch that can be adhered to the birthmark. It is possible to examine RNA elements on the patch (which were in the patch during removal of the birthmark) to determine if the RNA elements indicate the presence of skin cancer markers. Based on the evidence, the DermTech method is less invasive and more accurate than a standard biopsy. According to DermTech, their test is 99 % accurate.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored

SKIN also reported in another study that the DMTK stock’s patch was nearly five times more accurate than conventional visual methods in detecting melanoma. A study published in Dermatologist Magazine shows the DermTech patch has an accuracy of more than 91% in accurately detecting melanomas and more than 99% inaccurately excluding lesions that are not melanomas. Additionally, it has been reported that this method can reduce the need for a biopsy by 90%.

Even though some dermatological procedures have been rescheduled or canceled due to the coronavirus, DermTech’s revenue grew by 75% over the past year. Revenue increased 220 % year over year and nearly 30 % sequentially to $ 1.6 million for a common Medicare program in the fourth quarter.

DermTech Inc. (DMTK) went up 7.97% on Friday’s trading session, a rise equivalent to $4.25 from the previous market close price. During the trading session, the shares dropped to $51.57, while the day’s peak was recorded at $58.25. According to data provided by Barchart, DMTK finished the previous session at $53.35, with a trading volume of 3.15 million shares.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam

111365

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.